학술논문
Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: An alternative treatment for C2 deficiency diseases
Document Type
Article
Author
Source
In: BMC Immunology . (BMC Immunology, 20 August 2010, 11)
Subject
Language
English
ISSN
14712172